158 related articles for article (PubMed ID: 17327465)
1. Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro.
Hu W; Sorrentino C; Denison MS; Kolaja K; Fielden MR
Mol Pharmacol; 2007 Jun; 71(6):1475-86. PubMed ID: 17327465
[TBL] [Abstract][Full Text] [Related]
2. A novel approach to assess the health risk of aryl hydrocarbon receptor-bound contaminants via inhalation exposure using CYP1A1 expression as a biomarker.
Zhong H; Yu L; Lv X; Yu Y; Hu J
Ecotoxicol Environ Saf; 2024 Jul; 279():116466. PubMed ID: 38759533
[TBL] [Abstract][Full Text] [Related]
3. Bioluminescence imaging of Cyp1a1-luciferase reporter mice demonstrates prolonged activation of the aryl hydrocarbon receptor in the lung.
Veland N; Gleneadie HJ; Brown KE; Sardini A; Pombo J; Dimond A; Burns V; Sarkisyan K; Schiering C; Webster Z; Merkenschlager M; Fisher AG
Commun Biol; 2024 Apr; 7(1):442. PubMed ID: 38600349
[TBL] [Abstract][Full Text] [Related]
4. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
[TBL] [Abstract][Full Text] [Related]
5. Association between altered tryptophan metabolism, plasma aryl hydrocarbon receptor agonists, and inflammatory Chagas disease.
Ambrosio LF; Volpini X; Quiroz JN; Brugo MB; Knubel CP; Herrera MR; Fozzatti L; Avila Pacheco J; Clish CB; Takenaka MC; Beloscar J; Theumer MG; Quintana FJ; Perez AR; Motrán CC
Front Immunol; 2023; 14():1267641. PubMed ID: 38283348
[TBL] [Abstract][Full Text] [Related]
6. Gene-Environment Interactions: My Unique Journey.
Nebert DW
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():1-26. PubMed ID: 37788491
[TBL] [Abstract][Full Text] [Related]
7. Novel AHR Agonists for Treating Psoriasis.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):543-544. PubMed ID: 37197478
[TBL] [Abstract][Full Text] [Related]
8. The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta.
Stejskalova L; Pavek P
Curr Pharm Biotechnol; 2011 May; 12(5):715-30. PubMed ID: 21342125
[TBL] [Abstract][Full Text] [Related]
9. Control of immune-mediated pathology via the aryl hydrocarbon receptor.
Wheeler MA; Rothhammer V; Quintana FJ
J Biol Chem; 2017 Jul; 292(30):12383-12389. PubMed ID: 28615443
[TBL] [Abstract][Full Text] [Related]
10. AhR signalling and dioxin toxicity.
Sorg O
Toxicol Lett; 2014 Oct; 230(2):225-33. PubMed ID: 24239782
[TBL] [Abstract][Full Text] [Related]
11. TGF-β activation and lung fibrosis.
Tatler AL; Jenkins G
Proc Am Thorac Soc; 2012 Jul; 9(3):130-6. PubMed ID: 22802287
[TBL] [Abstract][Full Text] [Related]
12. The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Fernandez IE; Eickelberg O
Proc Am Thorac Soc; 2012 Jul; 9(3):111-6. PubMed ID: 22802283
[TBL] [Abstract][Full Text] [Related]
13. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.
Busbee PB; Rouse M; Nagarkatti M; Nagarkatti PS
Nutr Rev; 2013 Jun; 71(6):353-69. PubMed ID: 23731446
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor complex and the control of gene expression.
Beischlag TV; Luis Morales J; Hollingshead BD; Perdew GH
Crit Rev Eukaryot Gene Expr; 2008; 18(3):207-50. PubMed ID: 18540824
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor ligands in cancer: friend and foe.
Murray IA; Patterson AD; Perdew GH
Nat Rev Cancer; 2014 Dec; 14(12):801-14. PubMed ID: 25568920
[TBL] [Abstract][Full Text] [Related]
16. The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans.
Wincent E; Amini N; Luecke S; Glatt H; Bergman J; Crescenzi C; Rannug A; Rannug U
J Biol Chem; 2009 Jan; 284(5):2690-2696. PubMed ID: 19054769
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism.
Wohak LE; Krais AM; Kucab JE; Stertmann J; Øvrebø S; Seidel A; Phillips DH; Arlt VM
Arch Toxicol; 2016 Feb; 90(2):291-304. PubMed ID: 25398514
[TBL] [Abstract][Full Text] [Related]
18. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease.
Rothhammer V; Quintana FJ
Nat Rev Immunol; 2019 Mar; 19(3):184-197. PubMed ID: 30718831
[TBL] [Abstract][Full Text] [Related]
19. The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases.
Neavin DR; Liu D; Ray B; Weinshilboum RM
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513921
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis.
Reynolds LM; Wan M; Ding J; Taylor JR; Lohman K; Su D; Bennett BD; Porter DK; Gimple R; Pittman GS; Wang X; Howard TD; Siscovick D; Psaty BM; Shea S; Burke GL; Jacobs DR; Rich SS; Hixson JE; Stein JH; Stunnenberg H; Barr RG; Kaufman JD; Post WS; Hoeschele I; Herrington DM; Bell DA; Liu Y
Circ Cardiovasc Genet; 2015 Oct; 8(5):707-16. PubMed ID: 26307030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]